Monsanto President and Chief Operating Officer Brett Begemann says he is “increasingly confident” about glyphosate receiving re-registration in the European Union.
“Discussions have been progressing positively,” Begemann said on the company’s earnings conference call on June 28.
This is despite fears that European farmers would lose the active after regulators failed to renew its reauthorization and instead issued an 18-month extension until the end of 2017, saying they needed additional data. The impending decision follows the European Chemicals Agency’s (ECHA) Risk Assessment Committee’s conclusion in March that the available scientific evidence “did not meet the criteria to classify glyphosate as a carcinogen, as a mutagen or as toxic for reproduction.”
ECHA’s classification, together with the European Food Safety Authority’s risk assessment in late 2015 that also concluded glyphosate is unlikely to pose a carcinogenic hazard to humans, are poised to form the basis of the European Commission’s decision whether to renew the active for another 15 years.